7649:TSESugi Holdings Co., Ltd. Analysis

Sugi Holdings currently trades at 2,925 JPY, well below its DCF fair value of ~5,004 JPY and far under the industry average P/E of 24.8, indicating a sizable valuation cushion. The stock sits under its 20‑day (2,886 JPY), 50‑day (3,167 JPY) and 200‑day (3,501 JPY) moving averages, confirming a bearish price trend, yet the MACD histogram is positive (+35) and the signal line turned bullish, hinting at a possible short‑term reversal. RSI at 45.5 suggests the shares are not yet oversold, leaving room for upside.
On the balance sheet, cash of 111.2 bn JPY comfortably exceeds debt of 94.0 bn JPY, yielding a modest debt‑to‑equity of 32 % and a low beta of 0.07, which translates to limited systematic risk. Volatility over the past 30 days is elevated at 28 %, but trading volume remains stable, supporting adequate liquidity. The dividend payout ratio is only 14 % with a 0.6 % yield, making the dividend stream highly sustainable.
Operating metrics show 6.9 % revenue growth, a gross margin of 31.8 % and ROE of 16.6 %, positioning the company to benefit from Japan’s aging population and growing demand for pharmacy‑based health services. Given the valuation gap, solid cash generation, and defensive sector profile, the stock presents a compelling blend of value and modest growth potential.